SaintMed 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Viroje Vasusuttikulkant

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	no data
CEO 소유권	8.5%
경영진 평균 재임 기간	2.6yrs
이사회 평균 재임 기간	데이터 없음

최근 관리 업데이트

Recent updates

CEO

Viroje Vasusuttikulkant

no data

테뉴어

Dr. Viroje Vasusuttikulkant serves as Chief Executive Officer and Director at Saintmed Public Company Limited and served as its Acting Chief Financial Officer since April 1, 2022 until April 8, 2022.

리더십 팀

이름	위치	테뉴어	보상	소유권
Viroje Vasusuttikulkant	CEO & Director	no data	데이터 없음	8.52% THB 103.5m
Prapassorn Patamapinun	Chief Financial Officer	2.6yrs	데이터 없음	데이터 없음
Sorajja Boonprasit	COO & Director	no data	데이터 없음	12.07% THB 146.7m
Chonchanok Sumrongkij	Accounting Manager	1.5yrs	데이터 없음	데이터 없음
Rhamon Vasusuttikulkant	Chief Sales and Marketing Officer	2.6yrs	데이터 없음	9.83% THB 119.4m
Kittathum Nguansamarng	Chief of HR and IT & Director	no data	데이터 없음	5.73% THB 69.6m
Taveesak Boonprasit	Chief Service Officer & Director	no data	데이터 없음	5.78% THB 70.2m

2.6yrs

평균 재임 기간

경험이 풍부한 관리: SMD100 의 관리팀은 경험 ( 2.6 년 평균 재직 기간)으로 간주됩니다.

SaintMed 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

SaintMed Public Company Limited, Annual General Meeting, Apr 26, 2024

Saintmed Public Company Limited Appoints Prapassorn Patamapinum as Chief Financial Officer

Less than half of directors are independent

Saintmed Public Company Limited Appoints Pipop Udorn as Members of Audit Committee

Less than half of directors are independent

Saintmed Public Company Limited Announces Chief Finance Officer Changes

Recent updates

New minor risk - Share price stability

Investor sentiment improves as stock rises 15%

Second quarter 2024 earnings released: EPS: ฿0.025 (vs ฿0.13 in 2Q 2023)

Now 20% undervalued after recent price drop

First quarter 2024 earnings released: ฿0.05 loss per share (vs ฿0.036 profit in 1Q 2023)

Upcoming dividend of ฿0.15 per share

Full year 2023 earnings released: EPS: ฿0.35 (vs ฿1.32 in FY 2022)

SaintMed Public Company Limited, Annual General Meeting, Apr 26, 2024

Investor sentiment improves as stock rises 27%

Upcoming dividend of ฿0.15 per share at 20% yield

Third quarter 2023 earnings released: EPS: ฿0.054 (vs ฿0.30 in 3Q 2022)

Saintmed Public Company Limited Announces Dividend for the Operating Period from 01 January 2023 to 30 September 2023, Payable on 13 December 2023

Saintmed Public Company Limited (SET:SMD) announces an Equity Buyback for 22,000,000 shares, representing 9.79% for THB 120 million.

Second quarter 2023 earnings released: EPS: ฿0.13 (vs ฿0.39 in 2Q 2022)

First quarter 2023 earnings released: EPS: ฿0.036 (vs ฿0.61 in 1Q 2022)

Saintmed Public Company Limited Approves Dividend for the Year 2022, Payable on May 19, 2023

Upcoming dividend of ฿0.50 per share at 14% yield

Third quarter 2022 earnings released: EPS: ฿0.30 (vs ฿0.85 in 3Q 2021)

Saintmed Public Company Limited Appoints Prapassorn Patamapinum as Chief Financial Officer

Less than half of directors are independent

Upcoming dividend of ฿0.25 per share

Second quarter 2022 earnings released: EPS: ฿0.39 (vs ฿0.38 in 2Q 2021)

Saintmed Public Company Limited Announces Dividend for the Operating Period from 01 January 2022 to 30 June 2022, Payable on 14 September 2022

Saintmed Public Company Limited Appoints Pipop Udorn as Members of Audit Committee

First quarter 2022 earnings released: EPS: ฿0.64 (vs ฿0.048 in 1Q 2021)

Less than half of directors are independent

Saintmed Public Company Limited Announces Chief Finance Officer Changes

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Saintmed Public Company Limited, Annual General Meeting, Apr 26, 2022

Third quarter 2021 earnings released: EPS ฿0.89 (vs ฿0.069 in 3Q 2020)

Second quarter 2021 earnings released: EPS ฿0.39 (vs ฿0.069 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS ฿0.05 (vs ฿0.98 in 1Q 2020)

CEO

테뉴어

리더십 팀

평균 재임 기간